person · Reporting owner

Symonds Toby Edgcumbe

Disclosed activity across 1 company

Tapewire entity: 30836
SEC CIK: 0001619437

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
IPERIONX LtdIPX · Entity 5162	President	July 10, 2026	July 13, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

IPERIONX Ltd

Report date July 10, 2026 · Filed July 13, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
American Depository Shares (ADS)SEC Table II · derivative / convertible security	Direct	39,040	Reported balance After 2026-07-10 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-07-10 · Purchase · Acquired 2,040 · Balance 39,040 F3: IPX American Depository Shares (ADS) are traded on the NASDAQ. One ADS is equivalent to and convertible into 10 IPX Ordinary Shares (IPX Ordinary Shares are traded on the Australian Stock Exchange). F1: IPX Ordinary Shares are traded on the Australian Stock Exchange. F4: The purchase of 2,040 ADS is equivalent to 20,400 Ordinary Shares. With this purchase, Mr. Symonds now owns 39,040 ADS equivalent to 390,400 Ordinary Shares F5: 39,040 ADS is equivalent (and convertible into) 390,400 IPX Ordinary Shares
IPX Ordinary SharesSEC Table I · non-derivative	Direct	3,128,089	Reported balance Holding disclosure · report date 2026-07-10 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 3,128,089 F1: IPX Ordinary Shares are traded on the Australian Stock Exchange.
Restricted Stock Units (RSUs)SEC Table I · non-derivative	Direct	703,199	Reported balance Holding disclosure · report date 2026-07-10 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 703,199 F2: 302,666 vest in December 2026; 400,533 vest in April 2028
Performance Rights (A$4)SEC Table II · derivative / convertible security · Conversion / exercise price $4.00 · Expires 2028-12-21	Direct	1,110,000	Reported balance Holding disclosure · report date 2026-07-10 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance 1,110,000 F6: Australian dollars F1: IPX Ordinary Shares are traded on the Australian Stock Exchange.
Performance Rights (A$6)SEC Table II · derivative / convertible security · Conversion / exercise price $6.00 · Expires 2030-04-10	Direct	415,695	Reported balance Holding disclosure · report date 2026-07-10 · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · Balance 415,695 F6: Australian dollars F1: IPX Ordinary Shares are traded on the Australian Stock Exchange.
Performance Rights (A$7)SEC Table II · derivative / convertible security · Conversion / exercise price $7.00 · Expires 2030-04-10	Direct	415,695	Reported balance Holding disclosure · report date 2026-07-10 · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · Balance 415,695 F6: Australian dollars F1: IPX Ordinary Shares are traded on the Australian Stock Exchange.
Performance Rights (A$8)SEC Table II · derivative / convertible security · Conversion / exercise price $8.00 · Expires 2030-04-10	Direct	415,695	Reported balance Holding disclosure · report date 2026-07-10 · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · Balance 415,695 F6: Australian dollars F1: IPX Ordinary Shares are traded on the Australian Stock Exchange.
Performance Rights (A$18)SEC Table II · derivative / convertible security · Conversion / exercise price $18.00 · Expires 2031-04-02	Direct	226,047	Reported balance Holding disclosure · report date 2026-07-10 · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · Balance 226,047 F6: Australian dollars F1: IPX Ordinary Shares are traded on the Australian Stock Exchange.
Options (A$18)SEC Table II · derivative / convertible security · Conversion / exercise price $18.00 · Expires 2031-04-02	Direct	536,521	Reported balance Holding disclosure · report date 2026-07-10 · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · Balance 536,521 F6: Australian dollars F1: IPX Ordinary Shares are traded on the Australian Stock Exchange.
Options (A$22)SEC Table II · derivative / convertible security · Conversion / exercise price $22.00 · Expires 2031-04-02	Direct	607,244	Reported balance Holding disclosure · report date 2026-07-10 · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · Balance 607,244 F6: Australian dollars F1: IPX Ordinary Shares are traded on the Australian Stock Exchange.

Filing footnotes · ownership attribution and instrument terms

F1: IPX Ordinary Shares are traded on the Australian Stock Exchange.

F2: 302,666 vest in December 2026; 400,533 vest in April 2028

F3: IPX American Depository Shares (ADS) are traded on the NASDAQ. One ADS is equivalent to and convertible into 10 IPX Ordinary Shares (IPX Ordinary Shares are traded on the Australian Stock Exchange).

F4: The purchase of 2,040 ADS is equivalent to 20,400 Ordinary Shares. With this purchase, Mr. Symonds now owns 39,040 ADS equivalent to 390,400 Ordinary Shares

F5: 39,040 ADS is equivalent (and convertible into) 390,400 IPX Ordinary Shares

F6: Australian dollars

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 10, 2026 Filed Jul 13, 2026 13:11 UTC	IPERIONX Ltd IPX · Entity 5162	PurchaseAmerican Depository Shares (ADS) · Derivative	2,040	$24.55	$50,082.00	Disclosure SEC source: 0001619437-26-000007 · primary_doc.xml · derivative · entry 3 Symonds Toby Edgcumbe · CIK 0001619437 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,040 Underlying: Ordinary Shares · 20,400 shares Expires not disclosed F3 · security: IPX American Depository Shares (ADS) are traded on the NASDAQ. One ADS is equivalent to and convertible into 10 IPX Ordinary Shares (IPX Ordinary Shares are traded on the Australian Stock Exchange). F3 · derivative.exercise_price: IPX American Depository Shares (ADS) are traded on the NASDAQ. One ADS is equivalent to and convertible into 10 IPX Ordinary Shares (IPX Ordinary Shares are traded on the Australian Stock Exchange). F3 · derivative.exercise_date: IPX American Depository Shares (ADS) are traded on the NASDAQ. One ADS is equivalent to and convertible into 10 IPX Ordinary Shares (IPX Ordinary Shares are traded on the Australian Stock Exchange). F3 · derivative.expiration_date: IPX American Depository Shares (ADS) are traded on the NASDAQ. One ADS is equivalent to and convertible into 10 IPX Ordinary Shares (IPX Ordinary Shares are traded on the Australian Stock Exchange). F1 · derivative.underlying: IPX Ordinary Shares are traded on the Australian Stock Exchange. F4 · derivative.underlying_shares: The purchase of 2,040 ADS is equivalent to 20,400 Ordinary Shares. With this purchase, Mr. Symonds now owns 39,040 ADS equivalent to 390,400 Ordinary Shares F5 · balance_after: 39,040 ADS is equivalent (and convertible into) 390,400 IPX Ordinary Shares Read SEC document
April 28, 2026 Filed Apr 30, 2026 13:30 UTC	IPERIONX Ltd IPX · Entity 5162	PurchaseAmerican Depository Shares (ADS) · Derivative	3,000	$30.63	$91,890.00	Disclosure SEC source: 0001619437-26-000006 · primary_doc.xml · derivative · entry 3 Symonds Toby Edgcumbe · CIK 0001619437 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,000 Underlying: Ordinary Shares · 30,000 shares Expires not disclosed F4 · security: American Depository Shares (ADS) are traded on the Nasdaq F5 · derivative.exercise_price: One ADS is equivalent and exchangeable into ten ordinary shares F6 · price: This is the average price of ADS purchased. F5 · derivative.exercise_date: One ADS is equivalent and exchangeable into ten ordinary shares F5 · derivative.expiration_date: One ADS is equivalent and exchangeable into ten ordinary shares F1 · derivative.underlying: Ordinary Shares are traded on the Australian Stock Exchange (ASX). F5 · derivative.underlying_shares: One ADS is equivalent and exchangeable into ten ordinary shares F2 · balance_after: This is a correction since prior filing. See detailed notes below. Read SEC document
April 02, 2026 Filed Apr 2, 2026 23:56 UTC	IPERIONX Ltd IPX · Entity 5162	GrantOptions (A$22) · Derivative	607,244	Not disclosed Strike: $22.00	Not disclosed	Disclosure SEC source: 0001619437-26-000005 · primary_doc.xml · derivative · entry 10 Symonds Toby Edgcumbe · CIK 0001619437 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 607,244 Underlying: IPX Ordinary Shares · 607,244 shares Expires 2031-04-02 F5 · derivative.exercise_price: Australian Dollars. F7 · price: Each option confers the right to purchase one ordinary share at the conversion price. F1 · derivative.underlying: Ordinary Shares are traded on the Australian Stock Exchange (ASX). Read SEC document
April 02, 2026 Filed Apr 2, 2026 23:56 UTC	IPERIONX Ltd IPX · Entity 5162	GrantOptions (A$18) · Derivative	536,521	Not disclosed Strike: $18.00	Not disclosed	Disclosure SEC source: 0001619437-26-000005 · primary_doc.xml · derivative · entry 9 Symonds Toby Edgcumbe · CIK 0001619437 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 536,521 Underlying: IPX Ordinary Shares · 536,521 shares Expires 2031-04-02 F5 · derivative.exercise_price: Australian Dollars. F7 · price: Each option confers the right to purchase one ordinary share at the conversion price. F1 · derivative.underlying: Ordinary Shares are traded on the Australian Stock Exchange (ASX). Read SEC document
April 02, 2026 Filed Apr 2, 2026 23:56 UTC	IPERIONX Ltd IPX · Entity 5162	GrantPerformance Rights (A$18) · Derivative	226,047	Not disclosed Strike: $18.00	Not disclosed	Disclosure SEC source: 0001619437-26-000005 · primary_doc.xml · derivative · entry 8 Symonds Toby Edgcumbe · CIK 0001619437 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,047 Underlying: IPX Ordinary Shares · 226,047 shares Expires 2031-04-02 F5 · derivative.exercise_price: Australian Dollars. F6 · price: Each performance right is convertible into one ordinary share after performance criteria have been met. Performance criteria are (1) four years of continuous service through 04/02/2030, and (2) IPX stock price on the ASX reaching a thirty-day volume-weighted average price (VWAP) of A$18.00. F1 · derivative.underlying: Ordinary Shares are traded on the Australian Stock Exchange (ASX). Read SEC document
March 27, 2026 Filed Mar 30, 2026 13:23 UTC	IPERIONX Ltd IPX · Entity 5162	PurchaseAmerican Depository Shares	11,000	$23.87	$262,552.40	Disclosure SEC source: 0001619437-26-000004 · primary_doc.xml · nonDerivative · entry 1 Symonds Toby Edgcumbe · CIK 0001619437 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,000 F1 · security: American Depository Shares (ADS) are traded on the NASDAQ. One ADS is convertible into 10 ordinary shares (ordinary shares are traded on the Australian Stock Exchange). F2 · price: This is the average purchase price. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.